-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$107.8318.17% Upside
Nuvalent, Inc. Frequently Asked Questions
-
What analysts cover Nuvalent, Inc.?
Nuvalent, Inc. has been rated by research analysts at UBS, Guggenheim, Stifel Nicolaus, Raymond James, Jefferies, Leerink Partners in the past 90 days.